CARBAMIC ACID, (5-(ACETYLOXY)-14-CYANO-6,6A,7,13,14,16-HEXAHYDRO-9-METHOXY-8-(METHOXYMETHOXY)-4,10,23-TRIMETHYL-19-OXO-6,16-(EPITHIOPROPANOXYMETHANO)-7,13-IMINO-12H-1,3-DIOXOLO(7,8)ISOQUINO(3,2-B)(3)BENZAZOCIN-20-YL)-, 2-PROPENYL ESTER, (6R-(6R*,6AR*,7R*,13S*,14R*,16R*,20R*))-
UNII 752F4BB7J9
Substance Identification & Data
This profile provides standardized clinical and technical data for Carbamic Acid, (5-(acetyloxy)-14-cyano-6,6a,7,13,14,16-hexahydro-9-methoxy-8-(methoxymethoxy)-4,10,23-trimethyl-19-oxo-6,16-(epithiopropanoxymethano)-7,13-imino-12h-1,3-dioxolo(7,8)isoquino(3,2-b)(3)benzazocin-20-yl)-, 2-propenyl Ester, (6r-(6r*,6ar*,7r*,13s*,14r*,16r*,20r*))-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 752F4BB7J9.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 182201-62-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C37H42N4O11S CCRCOOJHJOMLQX-CZJJMISNSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Carbamic Acid, (5-(acetyloxy)-14-cyano-6,6a,7,13,14,16-hexahydro-9-methoxy-8-(methoxymethoxy)-4,10,23-trimethyl-19-oxo-6,16-(epithiopropanoxymethano)-7,13-imino-12h-1,3-dioxolo(7,8)isoquino(3,2-b)(3)benzazocin-20-yl)-, 2-propenyl Ester, (6r-(6r*,6ar*,7r*,13s*,14r*,16r*,20r*))-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.